These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12669387)

  • 41. [Antibacterial therapy of complicated urinary infections in outpatients].
    Rafal'skiĭ VV; Strachunskiĭ LS; Kogan MI; Petrov SB; Grinev AV; Shevelev AN
    Urologiia; 2004; (5):25-31. PubMed ID: 15560157
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection.
    Fletcher PS; Shattock RJ
    Curr Opin Investig Drugs; 2008 Feb; 9(2):189-200. PubMed ID: 18246522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Therapeutic use of fluoroquinolones].
    Lumio J
    Duodecim; 1999; 115(3):304-15. PubMed ID: 11830877
    [No Abstract]   [Full Text] [Related]  

  • 44. Alferminogene tadenovec, an angiogenic FGF4 gene therapy for coronary artery disease.
    Flynn A; O'Brien T
    IDrugs; 2008 Apr; 11(4):283-93. PubMed ID: 18379964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Empiric treatment of uncomplicated urinary tract infection with fluoroquinolones in older women in Israel: another lost treatment option?
    Kahan NR; Chinitz DP; Waitman DA; Dushnitzky D; Kahan E; Shapiro M
    Ann Pharmacother; 2006 Dec; 40(12):2223-7. PubMed ID: 17105833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections.
    Mazzei T; Cassetta MI; Fallani S; Arrigucci S; Novelli A
    Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S35-41. PubMed ID: 16829051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Taranabant, a novel cannabinoid type 1 receptor inverse agonist.
    Fremming BA; Boyd ST
    Curr Opin Investig Drugs; 2008 Oct; 9(10):1116-29. PubMed ID: 18821475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A study of non-antibiotic versus antibiotic prophylaxis for recurrent urinary-tract infections in women (the NAPRUTI study)].
    Beerepoot MA; Stobberingh EE; Geerlings SE
    Ned Tijdschr Geneeskd; 2006 Mar; 150(10):574-5. PubMed ID: 16566424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Some design issues in trials of microbicides for the prevention of HIV infection.
    Fleming TR; Richardson BA
    J Infect Dis; 2004 Aug; 190(4):666-74. PubMed ID: 15272392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Semapimod. Cytokine.
    Sitaraman SV; Hoteit M; Gewirtz AT
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1363-8. PubMed ID: 14758776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AGI-1067. AtheroGenics.
    Hatch GM
    Curr Opin Investig Drugs; 2002 Mar; 3(3):433-6. PubMed ID: 12054092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enoxacin: clinical results in lower respiratory tract infections.
    Grassi C; Mangiarotti P; Dal Prà ML
    J Chemother; 1989 Jul; 1(4 Suppl):790-2. PubMed ID: 16312641
    [No Abstract]   [Full Text] [Related]  

  • 54. Prulifloxacin: a new antibacterial fluoroquinolone.
    Prats G; Rossi V; Salvatori E; Mirelis B
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):27-41. PubMed ID: 16441207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid resolution of symptoms with ciprofloxacin therapy in 3859 hospitalised patients with urinary tract infection.
    Naber KG; Landen H
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S35-40. PubMed ID: 15037327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug evaluation: zanolimumab, a human monoclonal antibody targeted against CD4.
    Assaf C; Sterry W
    Curr Opin Mol Ther; 2007 Apr; 9(2):197-203. PubMed ID: 17458175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T-3811. Toyama/Bristol-Myers Squibb.
    Frechette R
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1706-11. PubMed ID: 11892932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. VasoCare. Vasogen.
    Visioli F
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1247-9. PubMed ID: 11717811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluoroquinolones in paediatrics--1995.
    Dagan R
    Drugs; 1995; 49 Suppl 2():92-9. PubMed ID: 8549423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Sparfloxacin (a long-acting difluoroquinolone)--an antibacterial preparation with the broad spectrum activity].
    Padeĭskaia EN
    Antibiot Khimioter; 2002; 47(1):26-35. PubMed ID: 12077937
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.